Drug Shortage Report for TEVA-MONTELUKAST

Last updated on 2020-05-14 History
Report ID 107992
Drug Identification Number 02355515
Brand name TEVA-MONTELUKAST
Common or Proper name MONTELUKAST 5MG CHEW TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) MONTELUKAST
Strength(s) 5MG
Dosage form(s) TABLET (CHEWABLE)
Route of administration ORAL
Packaging size 30 PP
ATC code R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-03-05
Estimated end date 2020-05-31
Actual end date 2020-05-08
Shortage status Resolved
Updated date 2020-05-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-05-14 French Compare
v5 2020-05-14 English Compare
v4 2020-04-02 French Compare
v3 2020-04-02 English Compare
v2 2020-03-06 French Compare
v1 2020-03-06 English Compare

Showing 1 to 6 of 6